<DOC>
	<DOCNO>NCT00115778</DOCNO>
	<brief_summary>The purpose study determine intravenous immunoglobulin ( IVIG ) prevent bacterial infection lung transplant patient low serum level immunoglobulin .</brief_summary>
	<brief_title>Intravenous Immunoglobulin ( IVIG ) Lung Transplantation</brief_title>
	<detailed_description>An increase risk infection despite intensive antimicrobial prophylaxis well-recognized complication lung transplantation . Recent evidence suggest immunosuppressive therapy solid organ transplantation may lead humoral immunodeficiency due hypogammaglobulinemia ( HGG ) . In lung transplant recipient HGG , IVIG therapy offer potential significantly decrease incidence severity infection , thereby reduce morbidity potentially mortality . Comparison : The investigator conduct randomized clinical trial IVIG versus placebo lung transplant patient severe HGG see IVIG decrease number bacterial infection patient .</detailed_description>
	<mesh_term>Agammaglobulinemia</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Lung transplant recipient &gt; 3 month transplant surgery IgG &lt; 500 mg/dL Stable medical regimen Acute rejection Active infection Contraindication IVIG Pregnancy Recent thrombotic event</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Hypogammaglobulinemia</keyword>
	<keyword>Lung Transplantation</keyword>
</DOC>